Standardized Procedural Practices of the Ontario Prenatal Screening Program for aneuploidies and open neural tube defects
- PMID: 22732525
- DOI: 10.1016/j.clinbiochem.2012.06.015
Standardized Procedural Practices of the Ontario Prenatal Screening Program for aneuploidies and open neural tube defects
Abstract
Background/objectives: The Ontario Prenatal Screening Program (OPSP) follows internationally recognized standardized procedures for laboratories and genetics clinics. However, it has been found that some procedures are subject to interpretation, so the current procedures are designed to facilitate a unified approach in the interpretation of literature recommendations. In Ontario, the OPSP offers multiple screening modalities with integrated prenatal screening (including both first and second trimester markers) being the most commonly chosen option. Other screening modalities include first trimester screening, second trimester quad screening, serum integrated screening, and NT-Quad.
Methods: The standardization was based on a literature review and on current practices in Ontario.
Results/discussion: The main finding of the review was a paucity of published data relating to the procedures and the decision-making processes involved in prenatal screening. The purpose of this publication is to provide the most up-to-date and pertinent information for clinical laboratory professionals involved with prenatal screening for Down syndrome, trisomy 18 and open neural tube defects.
Copyright © 2012 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Triploidy identified through second-trimester serum screening.Prenat Diagn. 2005 Mar;25(3):229-33. doi: 10.1002/pd.1115. Prenat Diagn. 2005. PMID: 15791661
-
Screening for fetal aneuploidy and neural tube defects.Genet Med. 2009 Nov;11(11):818-21. doi: 10.1097/GIM.0b013e3181bb267b. Genet Med. 2009. PMID: 19915395 Free PMC article.
-
First- and second-trimester screening: detection of aneuploidies other than Down syndrome.Obstet Gynecol. 2007 Sep;110(3):651-7. doi: 10.1097/01.AOG.0000278570.76392.a6. Obstet Gynecol. 2007. PMID: 17766613
-
Prenatal screening for Down syndrome and neural tube defects in twin pregnancies.Prenat Diagn. 2005 Sep;25(9):740-5. doi: 10.1002/pd.1258. Prenat Diagn. 2005. PMID: 16170842 Review.
-
Biochemical screening for congenital defects.Obstet Gynecol Clin North Am. 2004 Dec;31(4):857-72, xi. doi: 10.1016/j.ogc.2004.08.010. Obstet Gynecol Clin North Am. 2004. PMID: 15550339 Review.
Cited by
-
Patients' Knowledge of Prenatal Screening for Trisomy 21.J Genet Couns. 2018 Feb;27(1):95-103. doi: 10.1007/s10897-017-0126-3. Epub 2017 Jul 14. J Genet Couns. 2018. PMID: 28707139
-
Prenatal screening for trisomy 21: a comparative performance and cost analysis of different screening strategies.BMC Pregnancy Childbirth. 2020 Nov 23;20(1):713. doi: 10.1186/s12884-020-03394-w. BMC Pregnancy Childbirth. 2020. PMID: 33228595 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials